In the BioHarmony Drug Report Database

"Preview" Icon

Meloxicam

Anjeso, Mobic, Qmiiz Odt, Vivlodex, Zynrelef (meloxicam) is a small molecule pharmaceutical. Meloxicam was first approved as Anjeso on 2000-04-13. It is used to treat osteoarthritis and rheumatoid arthritis in the USA. It has been approved in Europe to treat postoperative pain. The pharmaceutical is active against prostaglandin G/H synthase 2. In addition, it is known to target prostaglandin G/H synthase 1. Mobic’s patents are valid until 2039-03-08 (FDA).

 

Trade Name

 

Zynrelef
 

Common Name

 

meloxicam
 

ChEMBL ID

 

CHEMBL599
 

Indication

 

osteoarthritis, postoperative pain, rheumatoid arthritis
 

Drug Class

 

Anti-inflammatory agents (isoxicam type)

Image (chem structure or protein)

Meloxicam structure rendering